Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and suppressing glucagon https://philipaogj534248.fitnell.com/76470927/comprehending-semaglutide-a-comprehensive-guide